Opioid access: more action needed, say hospital pharmacists

Patients should not have to pay for unsubsidised morphine products brought in to manage the current shortage, says the SHPA Yesterday (28 February 2023), the AJP reported that the Therapeutic Goods Administration has granted approval for several internationally-registered morphine oral liquid products to be supplied in Australia. The move was made following the discontinuation of

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous MedAdvisor to introduce new vax transaction fees
Next TWC winner ‘excited for what the future holds’